These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18428197)

  • 1. Development of a high drug load tablet formulation based on assessment of powder manufacturability: moving towards quality by design.
    Sun CC; Hou H; Gao P; Ma C; Medina C; Alvarez FJ
    J Pharm Sci; 2009 Jan; 98(1):239-47. PubMed ID: 18428197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating.
    Huang Z; Scicolone JV; Han X; Davé RN
    Int J Pharm; 2015 Jan; 478(2):447-55. PubMed ID: 25475016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
    Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
    J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered particles demonstrate improved flow properties at elevated drug loadings for direct compression manufacturing.
    Trementozzi AN; Leung CY; Osei-Yeboah F; Irdam E; Lin Y; MacPhee JM; Boulas P; Karki SB; Zawaneh PN
    Int J Pharm; 2017 May; 523(1):133-141. PubMed ID: 28284921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry coating of micronized API powders for improved dissolution of directly compacted tablets with high drug loading.
    Han X; Ghoroi C; Davé R
    Int J Pharm; 2013 Feb; 442(1-2):74-85. PubMed ID: 22921376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
    Kunnath K; Huang Z; Chen L; Zheng K; Davé R
    Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle Engineering of Excipients for Direct Compression: Understanding the Role of Material Properties.
    Mangal S; Meiser F; Morton D; Larson I
    Curr Pharm Des; 2015; 21(40):5877-89. PubMed ID: 26446468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microcrystalline cellulose based drug-composite formulation strategy for developing low dose drug tablets.
    Sun WJ; Sun CC
    Int J Pharm; 2020 Jul; 585():119517. PubMed ID: 32526333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of tableting properties measured with a multi-functional compaction instrument for several pharmaceutical excipients and actual tablet formulations.
    Osamura T; Takeuchi Y; Onodera R; Kitamura M; Takahashi Y; Tahara K; Takeuchi H
    Int J Pharm; 2016 Aug; 510(1):195-202. PubMed ID: 27184101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-proccessed excipients with enhanced direct compression functionality for improved tableting performance.
    Rojas J; Buckner I; Kumar V
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1159-70. PubMed ID: 22966909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematical approach of formulation and process development using roller compaction.
    Teng Y; Qiu Z; Wen H
    Eur J Pharm Biopharm; 2009 Oct; 73(2):219-29. PubMed ID: 19406236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multivariate formulation and process development platform for direct compression.
    Dhondt J; Bertels J; Kumar A; Van Hauwermeiren D; Ryckaert A; Van Snick B; Klingeleers D; Vervaet C; De Beer T
    Int J Pharm; 2022 Jul; 623():121962. PubMed ID: 35764260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of process parameters on content uniformity of a low dose active pharmaceutical ingredient in a tablet formulation according to GMP.
    Muselík J; Franc A; Doležel P; Goněc R; Krondlová A; Lukášová I
    Acta Pharm; 2014 Sep; 64(3):355-67. PubMed ID: 25296681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohesive, multicomponent, dense powder flow characterization by NIR.
    Benedetti C; Abatzoglou N; Simard JS; McDermott L; Léonard G; Cartilier L
    Int J Pharm; 2007 May; 336(2):292-301. PubMed ID: 17240094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal- a QbD Approach.
    Yamashita H; Sun CC
    Pharm Res; 2020 Jul; 37(8):153. PubMed ID: 32705421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To Study Capping or Lamination Tendency of Tablets Through Evaluation of Powder Rheological Properties and Tablet Mechanical Properties of Directly Compressible Blends.
    Dudhat SM; Kettler CN; Dave RH
    AAPS PharmSciTech; 2017 May; 18(4):1177-1189. PubMed ID: 27422654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between integrated continuous direct compression line and batch processing - The effect of raw material properties.
    Karttunen AP; Wikström H; Tajarobi P; Fransson M; Sparén A; Marucci M; Ketolainen J; Folestad S; Korhonen O; Abrahmsén-Alami S
    Eur J Pharm Sci; 2019 May; 133():40-53. PubMed ID: 30862514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression.
    Sun WJ; Aburub A; Sun CC
    J Pharm Sci; 2017 Jul; 106(7):1772-1777. PubMed ID: 28322940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enabling tablet product development of 5-fluorocytosine through integrated crystal and particle engineering.
    Perumalla SR; Sun CC
    J Pharm Sci; 2014 Apr; 103(4):1126-32. PubMed ID: 24515970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a continuous twin screw granulation and drying system during formulation development and process optimization.
    Vercruysse J; Peeters E; Fonteyne M; Cappuyns P; Delaet U; Van Assche I; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2015 Jan; 89():239-47. PubMed ID: 25528462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.